Xarelto Lawsuits Claim Blood Thinner Is Linked to Fatal Bleeding

July 24, 2014 Last Updated on February 19, 2015

Comments |

At A Glance

This Alert Affects:
Patients who suffered serious bleeding events after taking Xarelto.
What Is Xarelto?
Xarelto (rivaroxaban) is a blood thinner (anticoagulant) that is prescribed following knee and hip replacement surgeries to prevent the risk of blood clots. Xarelto has also been approved for use in patients with non-valvular atrial fibrillation (irregular heartbeats) to prevent the risk of strokes and systemic embolisms (severe blood clots).
What Injuries Have Been Linked to Xarelto?
Gastrointestinal bleeding, cerebral hemorrhaging and other types of internal bleeding.
Who's Getting Sued?
Bayer, Johnson & Johnson, and Johnson & Johnson's Janssen unit.
Why?
The lawsuits claim the drug is defective and unreasonably dangerous and that doctors and patients were not properly warned about the drug's risk of irreversible bleeding.
What Could I Get from a Lawsuit?
Compensation for medical bills, lost wages, pain and suffering, and in cases of death, funeral expenses and loss of projected earnings.
Type of Lawsuit
Mass Tort